Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Barnette

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|January 5, 2000
Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD)M S Barnette
Psychopharmacology Bulletin|January 1, 1983
Interaction of neuropeptides with calmodulin: a structure-activity studyM S Barnette, B Weiss
The American Journal of Physiology|January 1, 1992
Characterization of the antigen-induced contraction of colonic smooth muscle from sensitized guinea pigsM S Barnette, M Grous
Journal of Neurochemistry|August 1, 1985
Inhibition of calmodulin-stimulated phosphodiesterase activity by vasoactive intestinal peptideM S Barnette, B Weiss
Current Opinion in Pulmonary Medicine|March 31, 2000
New phosphodiesterase inhibitors as therapeutics for the treatment of chronic lung diseaseM S Barnette, D C Underwood
Agents and Actions. Supplements|January 1, 1995
Lipid mediators: mechanismsK B Glaser, M S Barnette
Biochemical Pharmacology|October 1, 1983
Inhibition of calmodulin activity by insect venom peptidesM S Barnette, R Daly, B Weiss
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Activation of cyclic AMP-dependent protein kinase during canine lower esophageal sphincter relaxationM S Barnette, M Grous, T J Torphy, et al.
Environmental Health Perspectives|December 1, 1994
Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthmaT J Torphy, M S Barnette, D W Hay, et al.
Annals of the New York Academy of Sciences|January 1, 1980
Pharmacological regulation of calmodulinB Weiss, W Prozialeck, M Cimino, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|January 5, 2000
Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD)M S Barnette
Psychopharmacology Bulletin|January 1, 1983
Interaction of neuropeptides with calmodulin: a structure-activity studyM S Barnette, B Weiss
The American Journal of Physiology|January 1, 1992
Characterization of the antigen-induced contraction of colonic smooth muscle from sensitized guinea pigsM S Barnette, M Grous
Journal of Neurochemistry|August 1, 1985
Inhibition of calmodulin-stimulated phosphodiesterase activity by vasoactive intestinal peptideM S Barnette, B Weiss
Current Opinion in Pulmonary Medicine|March 31, 2000
New phosphodiesterase inhibitors as therapeutics for the treatment of chronic lung diseaseM S Barnette, D C Underwood
Agents and Actions. Supplements|January 1, 1995
Lipid mediators: mechanismsK B Glaser, M S Barnette
Biochemical Pharmacology|October 1, 1983
Inhibition of calmodulin activity by insect venom peptidesM S Barnette, R Daly, B Weiss
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Activation of cyclic AMP-dependent protein kinase during canine lower esophageal sphincter relaxationM S Barnette, M Grous, T J Torphy, et al.
Environmental Health Perspectives|December 1, 1994
Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthmaT J Torphy, M S Barnette, D W Hay, et al.
Annals of the New York Academy of Sciences|January 1, 1980
Pharmacological regulation of calmodulinB Weiss, W Prozialeck, M Cimino, et al.
Pageof 3